Ameloblastin (Enamel Matrix Protein) (AMBN) (C-Term) Peptide
Quick Overview for Ameloblastin (Enamel Matrix Protein) (AMBN) (C-Term) Peptide (ABIN973164)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Sequence
- RPGFEGMPHN PAMGGDFTLE FDSPVAATKG PENEEGGAQG SPMPEANPDN
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-AMBN Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- AMBN (Ameloblastin (Enamel Matrix Protein) (AMBN))
-
Background
-
Ameloblastin is thought to represent an unique ameloblast-specific gene product that may be important in enamel matrix formation and mineralization. The gene is located on chromosome 4 near other genes associated with mineralized tissues: osteopontin, bone sialoprotein, and bone morphogenetic protein 3. Based on its cytogenetic location, this gene is a candidate gene for one form of the disorder, dentinogenesis imperfecta, and/or the disorder, autosomal dominant amylogenesis imperfecta.
Alias Symbols: -
Protein Size: 447 -
Molecular Weight
- 49 kDa
-
Gene ID
- 258
-
NCBI Accession
- NM_016519, NP_057603
-
UniProt
- Q9NP70
Target
-